Deutsche Bank
NAVB

Deutsche Bank’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Deutsche Bank’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-25
Closed – – 5610
2018
Q3 		$0 Buy
+25
New +$95 ﹤0.01% 5684
2016
Q2 		– Sell
-1,263
Closed -$22K – 5443
2016
Q1 		$22K Sell
1,263
-1,322
-51% -$25.4K ﹤0.01% 4619
2015
Q4 		$68K Sell
2,585
-6,835
-73% -$237K ﹤0.01% 4249
2015
Q3 		$428K Sell
9,420
-391
-4% -$14.7K ﹤0.01% 3447
2015
Q2 		$315K Buy
9,811
+1,796
+22% +$52.2K ﹤0.01% 3649
2015
Q1 		$254K Buy
8,015
+11
+0.1% +$372 ﹤0.01% 3673
2014
Q4 		$302K Sell
8,004
-2,178
-21% -$59.9K ﹤0.01% 4053
2014
Q3 		$268K Buy
10,182
+269
+3% +$7.12K ﹤0.01% 3905
2014
Q2 		$291K Sell
9,913
-3,604
-27% -$117K ﹤0.01% 3876
2014
Q1 		$499K Buy
13,517
+556
+4% +$21.1K ﹤0.01% 3336
2013
Q4 		$536K Sell
12,961
-6,026
-32% -$236K ﹤0.01% 3074
2013
Q3 		$1M Buy
18,987
+3,824
+25% +$223K ﹤0.01% 2968
2013
Q2 		$808K Buy
+15,163
New +$757K ﹤0.01% 2850

Other funds holding NAVB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deutsche Bank's NAVB Position: Q4 2018 in Review

Deutsche Bank sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q4 2018, closing a stake of 25 shares.

Deutsche Bank first reported a position in NAVB in Q2 2013 and held it in 13 quarters. The position peaked at $1M in Q3 2013. 56 funds tracked by Wall St. Rank hold NAVB as of Q4 2018.

  • Deutsche Bank reported no remaining Navidea Biopharmaceuticals Inc. position as of Q4 2018 after selling out during the quarter.
  • Deutsche Bank sold 25 Navidea Biopharmaceuticals Inc. shares in Q4 2018.
  • Deutsche Bank first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and held it in 13 quarters.
  • Deutsche Bank's Navidea Biopharmaceuticals Inc. position peaked at $1M in Q3 2013.
  • 56 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q4 2018.

Based on Deutsche Bank's 13F filing for Q4 2018, filed 14 Feb 2019.